Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States

By sjmartinez • April 11, 2025

Luo Y, Assassi S, Mayes MD, Frech TM, Steen VD, Richardson C, Chung L, Sandorfi N, VanBuren JM, Harding M, Alvey JS, Skaug B, McMahan Z, Lakin KS, Zahn C, Bracken SJ, Lebiedz-Odrobina DJ, Molitor JA, Evnin LB, Moore DF, Shah A, Castelino FV, Volkmann ER, Hant FN, Makol A, Shah AA, Hummers LK, Gordon JK, Khanna D, Bernstein EJ. Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States. Ann Am Thorac Soc. 2025 Apr 10. doi: 10.1513/AnnalsATS.202410-1045RL. Epub ahead of print. PMID: 40208257.

Tags: Publications, Rheumatology

Pre-procedural simulation of the right atrium to left ventricle puncture through the inferoseptal process using cardiac computed tomography

Miyazaki Y, Mori S, Bertog S, Shivkumar K, Tholakanahalli V. Pre-procedural simulation of the right atrium to left ventricle puncture through the inferoseptal process using[...]

Assessing Capacity and Exploring Goals of Care in Locked-In Syndrome: A Clinician’s Guide

Karlin D, Smolenski J, Callies DE, Raho JA. Assessing Capacity and Exploring Goals of Care in Locked-In Syndrome: A Clinician's Guide. Neurol Clin Pract. 2025[...]

Inequities in weathering California wildfires

Wong MS, Steers WN, Washington DL. Inequities in weathering California wildfires. Health Aff Sch. 2025 Jul 23;3(8):qxaf147. doi: 10.1093/haschl/qxaf147. PMID: 40896386; PMCID: PMC12397747.